4164 Stock Overview
Operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Nahdi Medical Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س133.40 |
| 52 Week High | ر.س183.40 |
| 52 Week Low | ر.س129.00 |
| Beta | 0.16 |
| 1 Month Change | -4.71% |
| 3 Month Change | -5.92% |
| 1 Year Change | -23.07% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -11.07% |
Recent News & Updates
There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings
Apr 25
Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00
Mar 21Recent updates
There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings
Apr 25Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00
Mar 21The Returns On Capital At Nahdi Medical (TADAWUL:4164) Don't Inspire Confidence
Jan 07Analyst Estimates: Here's What Brokers Think Of Nahdi Medical Company (TADAWUL:4164) After Its First-Quarter Report
Aug 07Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Jul 25Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Mar 22Nahdi Medical Company's (TADAWUL:4164) Price Is Out Of Tune With Earnings
Dec 13We Think Nahdi Medical's (TADAWUL:4164) Profit Is Only A Baseline For What They Can Achieve
Aug 20Are Investors Undervaluing Nahdi Medical Company (TADAWUL:4164) By 27%?
Aug 01Shareholder Returns
| 4164 | SA Consumer Retailing | SA Market | |
|---|---|---|---|
| 7D | -2.5% | -5.1% | 0.5% |
| 1Y | -23.1% | -7.4% | -2.1% |
Return vs Industry: 4164 underperformed the SA Consumer Retailing industry which returned -7.4% over the past year.
Return vs Market: 4164 underperformed the SA Market which returned -2.1% over the past year.
Price Volatility
| 4164 volatility | |
|---|---|
| 4164 Average Weekly Movement | 2.6% |
| Consumer Retailing Industry Average Movement | 5.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SA Market | 8.1% |
| 10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 4164 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4164's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Yasser Ghulam Abdulaziz Joharji | www.nahdi.sa |
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as health and wellness, mom and baby, beauty, and everyday essential products through retail and online stores. It also provides healthcare services, including polyclinics, express clinics, telemedicine services, and home healthcare, as well as operates an E-Pharmacist platform.
Nahdi Medical Company Fundamentals Summary
| 4164 fundamental statistics | |
|---|---|
| Market cap | ر.س17.39b |
| Earnings (TTM) | ر.س881.22m |
| Revenue (TTM) | ر.س8.87b |
19.7x
P/E Ratio2.0x
P/S RatioIs 4164 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4164 income statement (TTM) | |
|---|---|
| Revenue | ر.س8.87b |
| Cost of Revenue | ر.س5.46b |
| Gross Profit | ر.س3.41b |
| Other Expenses | ر.س2.53b |
| Earnings | ر.س881.22m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.78 |
| Gross Margin | 38.43% |
| Net Profit Margin | 9.94% |
| Debt/Equity Ratio | 0% |
How did 4164 perform over the long term?
See historical performance and comparison